CAS: 380894-77-9; Diethyl ((5-(3-Fluorophenyl)Pyridin-2-yl)Methyl)Phosphonate

该化合物是一种化学化合物,其特点是其磷酸酯结构,其中包括与二乙基酯组群相连的磷酸酸酯,其存在有助于其独特的化学特性,包括潜在的生物活动.由于磷酸功能组,该化合物可能呈现中度至高度的极性,可从事氢联结和离子相互作用.其分子结构表明其在药用化学中的潜在应用,特别是在制药或农用化学的开发中.氟原子可能会提高脂性,影响化合物与生物目标的相互作用.此外,该化合物的稳定性和再活性可能受到酯组群的影响,这些子群在某些条件下可能会进行水解.

结构式图片

相似化合物

75754-04-0 380894-77-9 181705-88-4

上下游产品

[(5-bromo-2-pyridinyl)methyl]-phosphonic acid diethyl ester 3-fluorophenylboronic acid diethyl chlorophosphate (6-methylpyridin-3-yl)trifluoromethanesulfonate 26H28FNO2C26H28FNO2

合成工艺路线路线简述

    氯磷酸二乙酯置于lithium Diisopropyl Amide,氯化铵体系中,用 四氢呋喃,正己烷,正庚烷,水 作为反应溶剂,化学反应 1.0H,以85%的收率获得产物[[5-(3-氟苯基)-2-吡啶基]甲基]膦酸二乙酯
    参考文献:Wo2006/76564
    标题:Wo2006/76564

    海关参考信息

    专利信息


    专利号:US-8273790-B2
    优先权日:2005-01-14
    标 题:Exo-selective synthesis of himbacine analogs
    发明人:THIRUVENGADAM TIRUVETTIPURAM K; SUDHAKAR ANANTHA; LIM NGIAP KIE; KWOK DAW-IONG; WU GEORGE G; WANG TAO; HUANG MINGSHENG; GREEN MICHAEL D
    权利人:THIRUVENGADAM TIRUVETTIPURAM K; SUDHAKAR ANANTHA; LIM NGIAP KIE; KWOK DAW-IONG; WU GEORGE G; WANG TAO; HUANG MINGSHENG; GREEN MICHAEL D; SCHERING CORP
    摘要:This application discloses a novel process for the synthesis of himbacine analogs, as well as the compounds produced thereby. The synthesis proceeds by alternative routes including the cyclic ketal amide route, the chiral carbamate amide route, and the chiral carbamate ester route. The compounds produced thereby are useful as thrombin receptor antagonists. The chemistry disclosed herein is exemplified in the following synthesis sequence:

    专利号:US-7626045-B2
    优先权日:2005-01-14
    标题:Synthesis of himbacine analogs
    发明人:THIRUVENGADAM TIRUVETTIPURAM K; WANG TAO; LIAO JING; CHIU JOHN S; TSAI DAVID J S; LEE HONG-CHANG; WU WENXUE; FU XIAOYONG
    权利人:SCHERING CORP
    摘要:The present invention relates to an improved process for preparing himbacine analogs. The compounds are useful as thrombin receptor antagonists. The improved process may allow for at least one of easier purification by crystallization, easier scalability, and improved process yield on the desired enantiomer. n An example of a step in the synthesis of such a himbacine analog is as follows:

    专利号:US-8329905-B2
    优先权日:2006-06-30
    标 题 :Synthesis of diethyl{[5-(3-fluorophenyl)-pyridine-2yl]methyl}phosphonate
    发明人:YONG KELVIN H; ZAVIALOV ILIA A; YIN JIANGUO; FU XIAOYONG; THIRUVENGADAM THIRUVETTIPURAM K
    权利人:YONG KELVIN H; ZAVIALOV ILIA A; YIN JIANGUO; FU XIAOYONG; THIRUVENGADAM THIRUVETTIPURAM K; MERCK SHARP & DOHME
    摘要:This application discloses a novel process for the preparation of phosphonate esters useful as intermediates in the preparation of himbacine analogs, themselves useful as thrombin receptor antagonists. The chemistry taught herein can be exemplified by the following scheme: n nwherein R 9 is selected from alkyl, aryl heteroaryl and arylalkyl groups having 1 to 10 carbon atoms, and R 11 is selected independently for each occurrence from alkyl, aryl heteroaryl and arylalkyl groups having 1 to 10 carbon atoms and hydrogen, X 2 is Cl, Br, or I; X 3 is selected from Cl and Br; and PdL n is a supported palladium metal catalyst or a soluble heterogeneous palladium catalyst. The L-derivatizing reagent is a moiety which converts the alcohol functional group of compound 137D to any leaving group which can be displaced by a triorgano-phosphite phosphonating agent.

    专利号:US-8618314-B2
    优先权日:2005-01-14
    标 题 :Exo- and diastereo-selective synthesis of himbacine analogs
    发明人:WU GEORGE G; SUDHAKAR ANANTHA; WANG TAO; XIE JI; CHEN FRANK X; POIRIER MARC; HUANG MINGSHENG; SABESAN VIJAY; KWOK DAW-LONG; CUI JIAN; YANG XIAOJING; THIRUVENGADAM TIRUVETTIPURAM K; LIAO JING; ZAVIALOV ILIA; NGUYEN HOA N; LIM NGIAP KIE
    权利人:WU GEORGE G; SUDHAKAR ANANTHA; WANG TAO; XIE JI; CHEN FRANK X; POIRIER MARC; HUANG MINGSHENG; SABESAN VIJAY; KWOK DAW-LONG; CUI JIAN; YANG XIAOJING; THIRUVENGADAM TIRUVETTIPURAM K; LIAO JING; ZAVIALOV ILIA; NGUYEN HOA N; LIM NGIAP KIE; MERCK SHARP & DOHME
    摘要:This application discloses a novel process for the preparation of himbacine analogs useful as thrombin receptor antagonists. The process is based in part on the use of a base-promoted dynamic epimerization of a chiral nitro center. The chemistry taught herein can be exemplified by the following:

    专利号:US-7678948-B2
    优先权日:2006-06-30
    标 题:Synthesis of 3-(5-nitrocyclohex-1-enyl) acrylic acid and esters thereof
    发明人:THIRUVENGADAM TIRUVETTIPURAM K; WANG TAO; CHIU JOHN S; LIAO JING
    权利人:SCHERING CORP
    摘要:This application discloses provides a process for the introduction of nitro-group functionality into a compound which contains also a site of unsaturation and/or oxygen functionality by direct (one step) oxidation of an oxime functional group mediated by a molybdenum VI/VII peroxo complex, the process comprising:n (a) providing a substrate of Formula I containing an oxime functional group; nn n n n n n n n n n n n n n wherein R 1 and R 2 are selected independently from linear, branched or cyclic alkyl and linear, branched or cyclic alkenyl groups, optionally substituted, with the proviso that at least one of R 1 or R 2 contains a carbon/carbon double bond; and n n n (b) contacting said substrate of Formula I with a molybdenum oxidation complex, thereby oxidizing said oxime functional group to a nitro functional group to yield the structure of Formula III. n n n n n nWhere R 1 and R 2 are as defined above.

    专利号:JP-2012197307-A
    优先权日:2006-06-30
    标 题 :Synthesis of diethyl {[5- (3-fluorophenyl) -pyridin-2-yl] methyl} phosphonate used in the synthesis of himbacine analogues
    台州嘉诺华生物科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.canova.com.cn
    企业联系电话:0576-81122208、81101151👤
    📞台州嘉诺华生物科技有限公司 ⚠️参考联系方式

    电话:0576-81122208、81101151

    传真:0576-81122207
    邮箱:canova@canova.com.cn
    通信地址: 台州市黄岩区西城街道县前社区塔院头路76号
    邮编:
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:台州市黄岩区西城街道县前社区塔院头路76号
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    上海润栖医药科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.rochipharma.com
    企业联系电话:021-38751876👤
    📞上海润栖医药科技有限公司 ⚠️参考联系方式
    联系人:余义波
    电话:021-38751876
    手机:15000076078
    传真:021-50275764
    邮箱:info@rochipharma.com
    通信地址: 上海市浦东新区郭守敬路199号上海中医药创新园2楼201室
    邮编: 201203
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:上海市浦东新区郭守敬路199号上海中医药创新园2楼201室
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    上海博志研新药物技术有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.bocimed.com
    电话: 0086(21)5895-0312👤
    📞上海博志研新药物技术有限公司 ⚠️参考联系方式

    销售电话:0086(21)5895-0312
    邮箱:sales@bocimed.com
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    济南立德医药技术有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.leadchem.net
    企业联系电话:0531-68654990👤
    📞济南立德医药技术有限公司 ⚠️参考联系方式
    联系人:陈经理
    电话:0531-68654990
    手机:18560195202
    传真:0531-68654990
    邮箱:lead@leadchem.net
    通信地址: 济南市高新区颖秀路2766号415室
    邮编: 250101
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:济南市高新区颖秀路2766号415室
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    参考文献:10.1007/s12272-016-0788-7
    摘要:Park CM, Baek S, Kim S, Song J, Lee S, Kim M. Trans-fused 5-[(tert-Butoxtycarbonyl)amino]octahydroindenes as a protease activated receptor-1 (PAR1) antagonist. Archives of Pharmacal Research. 2016 Jul 12;39(9):1275–95. doi: 10.1007/s12272-016-0788-7.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知